New Treatment Targets and Approaches for Hepatitis B Virus

Title:New Treatment Targets and Approaches for Hepatitis B Virus

Volume: 15 Issue: 1

Author(s): Murat Afyon*Cumhur Artuk

Affiliation:

• GATA Haydarpasa Training Hospital, Primary Care and Examination, Family Health Center and the Naval Academy Clinic, Tuzla/Istanbul,Turkey

Keywords: Hepatitis B virus, treatment, nucleos(t)id analogues, cccDNA, immunoregulators, viral entry, traditional Chinese medicine.

Abstract: Introduction: With the development of the direct acting antivirals aganist hepatitis C virus (HCV), the treatment of HCV has showed significiant progress. However, hepatitis B virus (HBV) therapy is still a topic of discussion.

Objectives: Because of that approved agents for HBV have some disadvantages including indefinite therapy, drug resistance, adverse effects and persistence of covalently closed circular deoxyribonucleic acid (cccDNA), there is a need for new treatment targets and approaches for HBV. And, there are several trials about this subject. New treatment targets for HBV consist revers transcription, immunoregulation, cccDNA formation and regulation, maturation and secretion of infectious virions and subviral particules, viral receptor, entry and cytosolic transport, nucleocapsid assembly. Therapeutic vaccination and traditional Chinese medicine are the other options for novel agents for HBV treatment. We summarised new treatment targets and approaches for HBV.

Conclusion: It is a certain fact that large-scale studies about all these molecules and approaches are required, in order to highlight the efficiency, drug interaction, safety and appropriate dose.

Cite this article as:

Afyon Murat*, Artuk Cumhur, New Treatment Targets and Approaches for Hepatitis B Virus, Anti-Infective Agents 2017; 15 (1) . https://dx.doi.org/10.2174/2211352514666161025113118

DOI https://dx.doi.org/10.2174/2211352514666161025113118	Print ISSN 2211-3525
Publisher Name Bentham Science Publisher	Online ISSN 2211-3533